Global Milbemycin Oxime API Competitive Landscape Professional Research Report 2024

Research Summary

Milbemycin oxime is an active pharmaceutical ingredient (API) used primarily in veterinary medicine for the prevention and treatment of parasitic infections in dogs and cats. It belongs to the milbemycin class of compounds, which are macrocyclic lactones derived from fermentation processes involving Streptomyces bacteria. Milbemycin oxime works by disrupting the nervous system of parasites, including heartworms, roundworms, hookworms, and whipworms, leading to their paralysis and eventual death. It is commonly formulated into chewable tablets or oral suspensions for ease of administration to pets. Milbemycin oxime is often combined with other active ingredients to broaden its spectrum of activity against various parasites. It is considered safe and effective when used as directed by veterinarians, playing a crucial role in preventing and controlling parasitic infections in companion animals.

According to DIResearch's in-depth investigation and research, the global Milbemycin Oxime API market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Milbemycin Oxime API include Livzon Pharmaceutical Group Inc, Zhejiang Hisun Pharmaceutical Co., Ltd, Hubei Honch Pharmaceutical Co.,Ltd, JIANGSU LINGYUN PHARMACEUTICAL CO.? 1/4 ?LTD etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Milbemycin Oxime API. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Milbemycin Oxime API market. The report data covers historical data from 2018 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Milbemycin Oxime API market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Milbemycin Oxime API industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Milbemycin Oxime API Include:

Livzon Pharmaceutical Group Inc

Zhejiang Hisun Pharmaceutical Co., Ltd

Hubei Honch Pharmaceutical Co.,Ltd

JIANGSU LINGYUN PHARMACEUTICAL CO.? 1/4 ?LTD

Milbemycin Oxime API Product Segment Include:

98% Purity

Purity Greater than 98%

Milbemycin Oxime API Product Application Include:

Dog

Cat

Other

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Milbemycin Oxime API Capacity and Production Analysis

Chapter 3: Global Milbemycin Oxime API Industry PESTEL Analysis

Chapter 4: Global Milbemycin Oxime API Industry Porter's Five Forces Analysis

Chapter 5: Global Milbemycin Oxime API Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 6: Global Milbemycin Oxime API Market Size and Forecast by Type and Application Analysis

Chapter 7: North America Milbemycin Oxime API Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: Europe Milbemycin Oxime API Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: China Milbemycin Oxime API Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: APAC (Excl. China) Milbemycin Oxime API Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Latin America Milbemycin Oxime API Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Middle East and Africa Milbemycin Oxime API Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 13: Global Milbemycin Oxime API Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 16: Research Findings and Conclusion

Chapter 17: Methodology and Data Sources

Table of Contents

1 Milbemycin Oxime API Market Overview

1.1 Product Definition and Statistical Scope

1.2 Milbemycin Oxime API Product by Type

1.2.1 Global Milbemycin Oxime API Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 98% Purity

1.2.3 Purity Greater than 98%

1.3 Milbemycin Oxime API Product by Application

1.3.1 Global Milbemycin Oxime API Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 Dog

1.3.3 Cat

1.3.4 Other

1.4 Global Milbemycin Oxime API Market Revenue and Sales Analysis

1.4.1 Global Milbemycin Oxime API Market Size Analysis (2019-2030)

1.4.2 Global Milbemycin Oxime API Market Sales Analysis (2019-2030)

1.4.3 Global Milbemycin Oxime API Market Sales Price Trend Analysis (2019-2030)

1.5 Milbemycin Oxime API Market Development Status and Trends

1.5.1 Milbemycin Oxime API Industry Development Status Analysis

1.5.2 Milbemycin Oxime API Industry Development Trends Analysis

2 Global Milbemycin Oxime API Capacity and Production Analysis

2.1 Global Milbemycin Oxime API Production Capacity (2019-2030)

2.2 Global Milbemycin Oxime API Production by Region: 2023 VS 2024 VS 2030

2.3 Global Milbemycin Oxime API Production by Region

2.3.1 Global Milbemycin Oxime API Historic Production by Region (2019-2024)

2.3.2 Global Milbemycin Oxime API Forecasted Production by Region (2025-2030)

2.3.3 Global Milbemycin Oxime API Production Market Share by Region (2019-2030)

3 Milbemycin Oxime API Market PESTEL Analysis

3.1 Political Factors Analysis

3.2 Economic Factors Analysis

3.3 Social Factors Analysis

3.4 Technological Factors Analysis

3.5 Environmental Factors Analysis

3.6 Legal Factors Analysis

4 Milbemycin Oxime API Market Porter's Five Forces Analysis

4.1 Competitive Rivalry

4.2 Threat of New Entrants

4.3 Bargaining Power of Suppliers

4.4 Bargaining Power of Buyers

4.5 Threat of Substitutes

5 Global Milbemycin Oxime API Market Analysis by Regions

5.1 Milbemycin Oxime API Overall Market: 2023 VS 2024 VS 2030

5.2 Global Milbemycin Oxime API Revenue and Forecast Analysis (2019-2030)

5.2.1 Global Milbemycin Oxime API Revenue and Market Share by Region (2019-2024)

5.2.2 Global Milbemycin Oxime API Revenue Forecast by Region (2025-2030)

5.3 Global Milbemycin Oxime API Sales and Forecast Analysis (2019-2030)

5.3.1 Global Milbemycin Oxime API Sales and Market Share by Region (2019-2024)

5.3.2 Global Milbemycin Oxime API Sales Forecast by Region (2025-2030)

5.4 Global Milbemycin Oxime API Sales Price Trend Analysis (2019-2030)

6 Global Milbemycin Oxime API Market Size by Type and Application

6.1 Global Milbemycin Oxime API Market Size by Type

6.1.1 Global Milbemycin Oxime API Revenue and Forecast Analysis by Type (2019-2030)

6.1.2 Global Milbemycin Oxime API Sales and Forecast Analysis by Type (2019-2030)

6.2 Global Milbemycin Oxime API Market Size by Application

6.2.1 Global Milbemycin Oxime API Revenue and Forecast Analysis by Application (2019-2030)

6.2.2 Global Milbemycin Oxime API Sales and Forecast Analysis by Application (2019-2030)

7 North America

7.1 North America Milbemycin Oxime API Market Size and Growth Rate Analysis (2019-2030)

7.2 North America Key Manufacturers Analysis

7.3 North America Milbemycin Oxime API Market Size by Type

7.3.1 North America Milbemycin Oxime API Sales by Type (2019-2030)

7.3.2 North America Milbemycin Oxime API Revenue by Type (2019-2030)

7.4 North America Milbemycin Oxime API Market Size by Application

7.4.1 North America Milbemycin Oxime API Sales by Application (2019-2030)

7.4.2 North America Milbemycin Oxime API Revenue by Application (2019-2030)

7.5 North America Milbemycin Oxime API Market Size by Country

7.5.1 US

7.5.2 Canada

8 Europe

8.1 Europe Milbemycin Oxime API Market Size and Growth Rate Analysis (2019-2030)

8.2 Europe Key Manufacturers Analysis

8.3 Europe Milbemycin Oxime API Market Size by Type

8.3.1 Europe Milbemycin Oxime API Sales by Type (2019-2030)

8.3.2 Europe Milbemycin Oxime API Revenue by Type (2019-2030)

8.4 Europe Milbemycin Oxime API Market Size by Application

8.4.1 Europe Milbemycin Oxime API Sales by Application (2019-2030)

8.4.2 ? Europe Milbemycin Oxime API Revenue by Application (2019-2030)

8.5 Europe Milbemycin Oxime API Market Size by Country

8.5.1 Germany

8.5.2 France

8.5.3 United Kingdom

8.5.4 Italy

8.5.5 Spain

8.5.6 Benelux

9 China

9.1 China Milbemycin Oxime API Market Size and Growth Rate Analysis (2019-2030)

9.2 China Key Manufacturers Analysis

9.3 China Milbemycin Oxime API Market Size by Type

9.3.1 China Milbemycin Oxime API Sales by Type (2019-2030)

9.3.2 China Milbemycin Oxime API Revenue by Type (2019-2030)

9.4 China Milbemycin Oxime API Market Size by Application

9.4.1 China Milbemycin Oxime API Sales by Application (2019-2030)

9.4.2 China Milbemycin Oxime API Revenue by Application (2019-2030)

10 APAC (excl. China)

10.1 APAC (excl. China) Milbemycin Oxime API Market Size and Growth Rate Analysis (2019-2030)

10.2 APAC (excl. China) Key Manufacturers Analysis

10.3 APAC (excl. China) Milbemycin Oxime API Market Size by Type

10.3.1 APAC (excl. China) Milbemycin Oxime API Sales by Type (2019-2030)

10.3.2 APAC (excl. China) Milbemycin Oxime API Revenue by Type (2019-2030)

10.4 APAC (excl. China) Milbemycin Oxime API Market Size by Application

10.4.1 APAC (excl. China) Milbemycin Oxime API Sales by Application (2019-2030)

10.4.2 APAC (excl. China) Milbemycin Oxime API Revenue by Application (2019-2030)

10.5 APAC (excl. China) Milbemycin Oxime API Market Size by Country

10.5.1 Japan

10.5.2 South Korea

10.5.3 India

10.5.4 Australia

10.5.5 Indonesia

10.5.6 Vietnam

10.5.7 Malaysia

10.5.8 Thailand

11 Latin America

11.1 Latin America Milbemycin Oxime API Market Size and Growth Rate Analysis (2019-2030)

11.2 Latin America Key Manufacturers Analysis

11.3 Latin America Milbemycin Oxime API Market Size by Type

11.3.1 Latin America Milbemycin Oxime API Sales by Type (2019-2030)

11.3.2 Latin America Milbemycin Oxime API Revenue by Type (2019-2030)

11.4 Latin America Milbemycin Oxime API Market Size by Application

11.4.1 Latin America Milbemycin Oxime API Sales by Application (2019-2030)

11.4.2 Latin America Milbemycin Oxime API Revenue by Application (2019-2030)

11.5 Latin America Milbemycin Oxime API Market Size by Country

11.5.1 Mexico

11.5.2 Brazil

12 Middle East & Africa

12.1 Middle East & Africa Milbemycin Oxime API Market Size and Growth Rate Analysis (2019-2030)

12.2 Middle East & Africa Key Manufacturers Analysis

12.3 Middle East & Africa Milbemycin Oxime API Market Size by Type

12.3.1 Middle East & Africa Milbemycin Oxime API Sales by Type (2019-2030)

12.3.2 Middle East & Africa Milbemycin Oxime API Revenue by Type (2019-2030)

12.4 Middle East & Africa Milbemycin Oxime API Market Size by Application

12.4.1 Middle East & Africa Milbemycin Oxime API Sales by Application (2019-2030)

12.4.2 Middle East & Africa Milbemycin Oxime API Revenue by Application (2019-2030)

12.5 Middle East & Africa Milbemycin Oxime API Market Size by Country

12.5.1 Saudi Arabia

12.5.2 South Africa

13 Competition by Manufacturers

13.1 Global Milbemycin Oxime API Market Sales, Revenue and Price by Key Manufacturers (2020-2024)

13.1.1 Global Milbemycin Oxime API Market Sales by Key Manufacturers (2020-2024)

13.1.2 Global Milbemycin Oxime API Market Revenue by Key Manufacturers (2020-2024)

13.1.3 Global Milbemycin Oxime API Average Sales Price by Manufacturers (2020-2024)

13.2 Milbemycin Oxime API Competitive Landscape Analysis and Market Dynamic

13.2.1 Milbemycin Oxime API Competitive Landscape Analysis

13.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales

13.2.3 Market Dynamic

14 Key Companies Analysis

14.1 Livzon Pharmaceutical Group Inc

14.1.1 Livzon Pharmaceutical Group Inc Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

14.1.2 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Product Portfolio

14.1.3 Livzon Pharmaceutical Group Inc Milbemycin Oxime API Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14.2 Zhejiang Hisun Pharmaceutical Co., Ltd

14.2.1 Zhejiang Hisun Pharmaceutical Co., Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

14.2.2 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Product Portfolio

14.2.3 Zhejiang Hisun Pharmaceutical Co., Ltd Milbemycin Oxime API Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14.3 Hubei Honch Pharmaceutical Co.,Ltd

14.3.1 Hubei Honch Pharmaceutical Co.,Ltd Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

14.3.2 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Product Portfolio

14.3.3 Hubei Honch Pharmaceutical Co.,Ltd Milbemycin Oxime API Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

14.4 JIANGSU LINGYUN PHARMACEUTICAL CO.? 1/4 ?LTD

14.4.1 JIANGSU LINGYUN PHARMACEUTICAL CO.? 1/4 ?LTD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

14.4.2 JIANGSU LINGYUN PHARMACEUTICAL CO.? 1/4 ?LTD Milbemycin Oxime API Product Portfolio

14.4.3 JIANGSU LINGYUN PHARMACEUTICAL CO.? 1/4 ?LTD Milbemycin Oxime API Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024)

15 Industry Chain Analysis

15.1 Milbemycin Oxime API Industry Chain Analysis

15.2 Milbemycin Oxime API Industry Upstream Supply Analysis

15.2.1 Upstream Key Raw Material Supply Analysis

15.2.2 Raw Material Suppliers and Contact Information

15.3 Milbemycin Oxime API Typical Downstream Customers

15.4 Milbemycin Oxime API Sales Channel Analysis

16 Research Findings and Conclusion

17 Methodology and Data Source

17.1 Methodology/Research Approach

17.2 Research Scope

17.3 Benchmarks and Assumptions

17.4 Date Source

17.4.1 Primary Sources

17.4.2 Secondary Sources

17.5 Data Cross Validation

17.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Polystyrene-Plastic Material And Resins Market (2024 Edition): Analysis By End-User Industry (Packaging Industry, Construction, Consumer, Electronics, and Other End-User Industries), By Product Type, By Application, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Ultra High Molecular Weight Polyethylene (UHMWPE) Fiber Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Form (Tapes, Sheets and Films, Fibers, Rods & Tubes and Other Forms), Processing Method, Grade, Region, By Country: 2020-2030

Global Food & Beverage Non-woven Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Material (Polypropylene (PP), Polyethylene Terephthalate (PET), Polyethylene, Rayon and Other Materials), Product Type, End-Use, Region, By Country: 2020-2030

Global Transportation Protective Films Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Material Type (PP Films, PE Films, PVC Films, PET Films and Other Material Types), End-Use Industry, Class Type, Region, By Country: 2020-2030

Global Short Fiber Thermoplastic Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Resin Type (Polypropylene, Polyamide, PEEK, PBT and Other Resin Types), Application, Reinforcement Type, Region, By Country: 2020-2030

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support